M a modifier-mediated methylation characterized by diverse prognosis, tumor microenvironment, and immunotherapy response in hepatocellular carcinoma

HIGHLIGHTS

  • who: Fei Liu and collaborators from the Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China have published the Article: M A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma, in the Journal: Journal of Oncology of 16/08/2022
  • what: The experiments showed that ZC3H13 up-regulation exerted an inhibitory effect on proliferation and invasion of HCC cells, confirming the antiHCC effects of ZC3H13. Collectively, this research synthetically evaluated the m6A regulator-based m6A machinery phenotypes for HCC that were . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?